Actos Lawsuit

A Los Angeles Superior Court judge has set aside an April verdict that awarded $6.5 million to an Actos lawsuit plaintiff after finding that his expert witness failed to prove the diabetes drug specifically caused his bladder cancer, reports Thomson-Reuters.com. According an article published May...

A California man won $6.5 million last week in the Actos lawsuit he filed against a Japanese drug maker who failed to warn him of the diabetes drug’s potential to cause and/or worsen bladder cancer, according to Thomson Reuters News & Insight. According to the article published April 30th,...

Allegations that a popular diabetes drug may cause bladder cancer and other side effects continued to be denied by the manufacturer this week in closing arguments heard in the first trial for an Actos lawsuit in the U.S., Bloomberg.com reports. On April 16th, 2013, a lawyer for Takeda Pharmaceuti...

The nation’s first Actos lawsuit to go trial is moving forward in Los Angeles Superior Court.  According to Bloomberg.com, a clinical pharmacologist testifying as an expert for the Plaintiff said Tuesday  that internal emails indicate Takeda Pharmaceuticals put profits ahead of patient safety wh...

Today’s date is likely to mark a milestone in Actos lawsuits. According to a Feb. 19, 2013 report from Bloomberg.com, the first of more than 3,000 cases filed over the Takeda Pharmaceutical Co.-manufactured diabetes drug is set to go to trial in Los Angeles state court, and will hear allegation...

An Alabama Supreme Court ruling allowing patients taking generic drugs to file lawsuits against the brand name drug manufacturer may be a pivotal decision, and could set a precedent for patients injured by generic versions of other medications to file similar failure to warn claims against brand nam...

A West Virginia man seeking to have his Actos lawsuit heard in state court was granted his request in November when a federal judge remanded the case to Harrison County Circuit Court. The ruling by U.S. District Judge Irene Keeley was made at a Nov. 20 hearing after she determined the plaintiff d...

In the Fosamax lawsuits and Actos lawsuits that continue to be filed, hundreds of patients allege the name-brand drug makers failed to warn consumers of the dangerous side effects associated with the medications. Now, they are trying to do the same with generic drugs, but may soon hit a road bloc...

The pharmaceuticals company facing a rising number of Actos lawsuits filed over its diabetes drug recently reported a spike in sales during the first-half of its financial year, but that may not have been possible without the manufacturer’s acquisition of two U.S. drug companies, according to PMLi...

Watson Pharmaceuticals is the newest company to be approved to market a generic version of popular diabetes drug Actos (pioglitazone), manufactured by Takeda Pharmaceutical Inc., in spite of numerous concerns about Actos side effects such as increased risk of bladder cancer. A Washington U.S. Dis...